Latest Sulfoxides Stories
SEATTLE, Aug. 10, 2011 /PRNewswire/ -- The following statement is being issued by GCG Inc., Notice Administrator regarding the Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Docket No.
Horse Gold Unique Proprietary Formula Obliterates Gastric Pain in Horses Bradenton, FL (PRWEB) July 26, 2011 Horse Gold, makers of hyper-effective equine supplements created by horsemen for horsemen, officially released Gastromax3â„¢ paste, an affordable, once-a-day preventive anti-ulcer supplement for horses.
In an evaluation of contemporary antireflux therapies for chronic gastroesophageal reflux disease (GERD), most patients who received treatment with either the proton pump inhibitor esomeprazole or laparoscopic antireflux surgery achieved and remained in disease remission for 5 years.
FRAZER, Pa., May 6, 2011 /PRNewswire/ -- At the Society of General Internal Medicine's 34th Annual Meeting in Phoenix, Ariz. today, Cephalon, Inc. (Nasdaq: CEPH) presented positive results from a phase IV trial of nearly 400 people with excessive sleepiness associated with shift work disorder.
FRAZER, Pa., April 21, 2011 /PRNewswire/ -- Cephalon, Inc.
HOUSTON, April 19, 2011 /PRNewswire/ -- An Ohio woman suffered bone deterioration and broken bones because of hidden risks with pharmaceutical giant AstraZeneca's acid reflux drug Nexium, The Gibson Law Firm alleges in a lawsuit filed today in Texas federal court. Filed in the U.S.
MISSISSAUGA, Ontario, April 11, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today filed with the Securities and Exchange Commission a presentation in connection with its written consent solicitation to stockholders of Cephalon, Inc.
NEW ORLEANS, April 5, 2011 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (Takeda) announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate).
CHAPEL HILL, N.C., Feb. 14, 2011 /PRNewswire/ -- Thought Leader Select, a Research Triangle, NC firm focused on collaborations between the biopharmaceutical industry and the medical community, announces the launch of a new media partnership with biopharmaceutical industry blog Marketing4Health.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.